Your session is about to expire
← Back to Search
Lifestyle Program for Reducing Chronic Disease Risk
N/A
Waitlist Available
Led By Kimlin Ashing-Giwa
Research Sponsored by City of Hope Medical Center
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up up to 3 months
Awards & highlights
Study Summary
This trial is testing how well a lifestyle program called "Eat, Move, Live" works in reducing the risk of chronic disease in people who are medically vulnerable.
Who is the study for?
This trial is for Latina mothers or female guardians of elementary students who don't eat more than five servings of fruits and vegetables daily, nor exercise for 150 minutes a week. They must not have diabetes, consume a healthy diet, be physically active already, or have conditions that limit daily activities.Check my eligibility
What is being tested?
The Eat, Move, Live (EML) program aims to reduce chronic disease risk by promoting physical activity and healthier eating habits through educational sessions, dietary guidance, exercise plans, and questionnaires to track progress.See study design
What are the potential side effects?
Since this trial involves lifestyle changes like diet and exercise rather than medication there are generally no side effects. However some may experience muscle soreness from new physical activities or changes in digestion due to diet alterations.
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ up to 3 months
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~up to 3 months
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Primary outcome measures
Changes in hemoglobin A1c level measured using a point of care device A1CNow®
Changes in level of self reported 5-9 servings of fruits and vegetables using self evaluation and the daily food diary
Changes in plasma glucose level measured using point of care glucometer OneTouch Ultra® 2
+3 moreTrial Design
2Treatment groups
Experimental Treatment
Active Control
Group I: Group I (EML)Experimental Treatment5 Interventions
Participants complete an assessment on knowledge, attitudes, and behaviors at baseline and attend 2 weekday sessions comprised of interactive education segment that is culturally responsive, and based on the community EML program, and topics including: nutrition guideline, nutrition label reading, comparison shopping/grocery store tour, recipe modification and healthy food preparation, eating healthy on a budget, and making healthy choices outside the home (e.g., restaurants) and physical activity over 1 hour led by CHE, a physical activity conducted by Duarte Fitness Centers instructors over 30 minutes, and cooking/taste test demonstration co-led by the CHE and local chef over 30 minutes over 12 weeks. Participants are also prescribed and encouraged to participate in 3 days a week exercise classes (for > 30 minutes) including salsa, Zumba and other aerobic exercises that are provided at Duarte Fitness Center.
Group II: Group II (control)Active Control4 Interventions
Participants receive a fitness tracker to track their physical activity and be wait listed to receive the intervention during month 10-12.
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Behavioral Dietary Intervention
2016
N/A
~70
Exercise Intervention
2016
Completed Phase 4
~1330
Find a Location
Who is running the clinical trial?
National Cancer Institute (NCI)NIH
13,658 Previous Clinical Trials
40,924,591 Total Patients Enrolled
City of Hope Medical CenterLead Sponsor
565 Previous Clinical Trials
1,921,410 Total Patients Enrolled
Kimlin Ashing-GiwaPrincipal InvestigatorCity of Hope Medical Center
2 Previous Clinical Trials
245 Total Patients Enrolled
Media Library
Eligibility Criteria:
This trial includes the following eligibility criteria:- I cannot engage in physical activities due to my condition.I have been diagnosed with diabetes.I am a mother or female guardian of a child in elementary school.
Research Study Groups:
This trial has the following groups:- Group 1: Group I (EML)
- Group 2: Group II (control)
Awards:
This trial has 1 awards, including:- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
Timeline:
This trial has the following timeline:- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Who else is applying?
What site did they apply to?
City of Hope Medical Center
What portion of applicants met pre-screening criteria?
Met criteria
Recent research and studies
Share this study with friends
Copy Link
Messenger